Citadel Advisors
ICCM icon

Citadel Advisors’s IceCure Medical ICCM Stock Holding History

Citadel Advisors’s Portfolio ICCM Stock Details ICCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,239
Closed -$37.9K – 13281
2025
Q3 		$37.9K Sell
1,239
-512
-29% -$15.3K ﹤0.01% 12317
2025
Q2 		$52.3K Buy
+1,751
New +$56.3K ﹤0.01% 11746
2024
Q3 		– Sell
-5,650
Closed -$125K – 14666
2024
Q2 		$125K Buy
+5,650
New +$180K ﹤0.01% 10594
2024
Q1 		– Sell
-1,704
Closed -$54.7K – 14966
2023
Q4 		$54.7K Sell
1,704
-717
-30% -$19K ﹤0.01% 11687
2023
Q3 		$40.3K Buy
+2,421
New +$76.1K ﹤0.01% 11989
2022
Q2 		– Sell
-480
Closed -$35K – 13405
2022
Q1 		$35K Buy
+480
New +$37.2K ﹤0.01% 13016

Other funds holding ICCM

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
GCM
Gunderson Capital Management Mt. Pleasant, South Carolina $370M AUM 211.56% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return

Citadel Advisors's ICCM Position: Q4 2025 in Review

Citadel Advisors sold out of IceCure Medical (ICCM) in Q4 2025, closing a stake of 1,239 shares — an estimated $37.9K sold.

Citadel Advisors first reported a position in ICCM in Q1 2022 and held it in 6 quarters. The position peaked at $125K in Q2 2024. 18 funds tracked by Wall St. Rank hold ICCM as of Q4 2025.

  • Citadel Advisors reported no remaining IceCure Medical position as of Q4 2025 after selling out during the quarter.
  • Citadel Advisors sold 1,239 IceCure Medical shares in Q4 2025, an estimated $37.9K.
  • Citadel Advisors first reported a position in IceCure Medical in Q1 2022 and held it in 6 quarters.
  • Citadel Advisors's IceCure Medical position peaked at $125K in Q2 2024.
  • 18 funds tracked by Wall St. Rank held IceCure Medical as of Q4 2025.

Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.